J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
India
· Delayed Price · Currency is INR | Market Cap | 252.54B |
| Revenue (ttm) | 38.30B |
| Net Income (ttm) | 6.40B |
| Shares Out | 155.68M |
| EPS (ttm) | 40.20 |
| PE Ratio | 40.35 |
| Forward PE | 31.77 |
| Dividend | 17.00 (1.05%) |
| Ex-Dividend Date | Feb 7, 2025 |
| Volume | 2,488 |
| Average Volume | 13,709 |
| Open | 1,626.00 |
| Previous Close | 1,629.55 |
| Day's Range | 1,620.60 - 1,664.00 |
| 52-Week Range | 1,434.85 - 2,029.00 |
| Beta | 0.05 |
| RSI | 48.83 |
| Earnings Date | May 16, 2025 |
About BOM:506943
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-cen... [Read more]
Financial Performance
In 2023, BOM:506943's revenue was 34.84 billion, an increase of 10.63% compared to the previous year's 31.49 billion. Earnings were 5.53 billion, an increase of 34.84%.
Financial StatementsNews
JB Chemicals & Pharma shares slide 6% after large block deal of 5.7% equity
Shares of JB Chemicals & Pharmaceuticals declined sharply on Thursday, falling 6.68% to ₹1,594.65 on the NSE, following a large block deal involving 5.78% equity. As per exchange data, around 90 lakh ...
Stocks to watch today: Infosys, Wipro, Ashok Leyland, HUL, Bajaj Finance, BSE, NBCC, UPL, Max Financial, JB Chemicals in focus [27 March]
Indian equity markets are likely to witness stock-specific action on Thursday, March 27, as several companies announced key developments, strategic deals, stake sales, and corporate updates. Here’s a ...
Stocks to watch today: JB Chemicals, Infosys, Bajaj Finserv, Wipro, Bharat Forge, Marico, Sterlite Technologies in focus on March 26, 2025
Several key corporate announcements are set to drive investor attention on March 26, with developments across IT, pharma, defence, infra, and financial services sectors. Here are the top stocks likely...
KKR, JB Chemicals promoter, to sell 10% for Rs 2.6k crore
India Business News: MUMBAI: Tau Investment Holdings, an arm of global private equity major KKR, the promoter of JB Chemicals, is selling about 1.
JB Chemicals and Pharma: Promoter KKR entity to sell 10.2% stake worth Rs 2,575 crore via block tomorrow
Shares of JB Chemicals & Pharmaceuticals Ltd are likely to remain in focus following media reports from CNBC-Awaaz suggest a large block deal has been launched by promoter group entity Tau Investment ...
KKR Is Said to Consider Selling $750 Million Stake in JB Pharma
KKR & Co. is considering selling some of its controlling stake in JB Chemicals & Pharmaceuticals Ltd. via a block trade in the market, according to people familiar with the matter.
Stocks to Buy This Diwali: Kotak Securities sees JB Chemicals & Pharma reaching ₹2,255, with a 19.2% upside
Kotak Securities has added JB Chemicals & Pharma to its Diwali 2024 stock picks, assigning it a “Buy” rating with a target price of ₹2,255. Currently trading at ₹1,891, JB Chemicals offers an upside p...
Pharma Stocks Update: Natco Pharma gains 2.99%, Glenmark rises 0.07%, Granules falls 3.83%
As of 2:38 PM, the Nifty Pharma index saw a mixed performance with some stocks showing notable gains while others faced losses. Natco Pharma, Glenmark, and Ajanta Pharma were the top gainers, while Gr...
Pharma Stocks Update: Granules up 3.56%, Ajanta Pharma gains 2.24% while JB Chemicals drops 2.82%, Mankind Pharma down 1.40% in mixed pharma stock performance
Pharma stocks have shown mixed performance in today’s trading session, with some major players gaining ground while others face declines. As of now, here’s how key pharmaceutical stocks are performing...
JB Chemicals faces valuation dispute over KKR’s 54% equity stake, potential M&A deal withdrawal looms; stock falls 4.28%
The largest M&A deal in India’s pharmaceutical industry for 2024 is reportedly facing significant hurdles. According to ET Now, JB Chemicals is in a disagreement over the valuation of KKR’s 54% equity...
Torrent Is Said to Seek Raising $3 Billion for KKR’s Stake in JB
Torrent Pharmaceuticals Ltd. is considering raising as much as $3 billion from global banks as the Indian drugmaker seeks to acquire a controlling stake in JB Chemicals & Pharmaceuticals Ltd., accordi...